Cost-benefit analysis of VKA versus NOAC treatment in German patients with atrial fibrillation utilizing patient self-testing
**Background:** Clinical complications of long-term anticoagulation in patients with atrial fibrillation cause significant morbidity and have a substantial economic impact on the healthcare system. **Objective:** To assess the cost-benefit by implementing patient self-testing (PST) in German patie...
Saved in:
Main Authors: | Roland Diel, Niklas Lampenius |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2019-08-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9774 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid Point-of-Care Influenza Testing for Patients in German Emergency Rooms – A Cost-Benefit Analysis
by: Roland Diel, et al.
Published: (2019-12-01) -
Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
by: Carlos Rubio-Terrés, et al.
Published: (2016-02-01) -
Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
by: Yazid Aoudia, et al.
Published: (2017-05-01) -
The Effects of Catheter Ablation Therapy on Medication Use and Expenditures in Patients with Atrial Fibrillation
by: Matthew R. Reynolds, et al.
Published: (2014-10-01) -
Detecting Atrial Fibrillation Using Smartwatches
by: Agnieszka Kulczycka-Rowicka, et al.
Published: (2025-02-01)